Endometrial Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are receiving primary (first-time) treatment for their condition
- People who have had a full staging surgery, including removal of the uterus, both ovaries, and fallopian tubes, along with surgical staging
- People whose post-surgery tissue samples confirmed a diagnosis of endometrial adenocarcinoma (a specific type of uterine cancer)
- People whose cancer has been classified as Stage III endometrial cancer according to the FIGO 2009 staging system
- People who are enrolling within 8 weeks of their surgery date
- People whose blood and organ function results meet the required levels, including healthy white blood cell counts, platelet counts, liver function markers, and kidney function markers (confirm specific values with the trial site)
- People with a Karnofsky performance score of 60 or above, which is a measure of general health and ability to carry out daily activities
- People who are willing to participate voluntarily, sign a consent form, and attend follow-up appointments
Who may not be able to join:
- People who have already received any additional treatment after surgery, such as radiation therapy, chemotherapy, or hormone therapy
- People who had visible tumour remaining in the body after their surgery
- People who have another active cancer of a serious nature
- People with certain heart conditions, including a heart attack within the past 3 months, unstable chest pain, or uncontrolled irregular heartbeat, that would prevent them from safely receiving radiation or chemotherapy
- People whose estimated life expectancy is less than 6 months
- People who are unable or unwilling to follow the requirements of the study
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +861088324381
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Progress-free survival
Can't join this trial?
Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.